1
Clinical Trials associated with 18F-LY3950321A Phase 1, Open-label Study to Evaluate the Biodistribution and Safety of 18F-LY3950321 (18F-MNI-1256) in Healthy Subjects
18F-LY3950321 (also known as 18F-MNI-1256) is a radiolabeled positron emission tomography (PET) tracer targeting granzyme B. The overall goal of this protocol is to evaluate the safety, tolerability, and radiation dosimetry of 18F-LY3950321.
100 Clinical Results associated with 18F-LY3950321
100 Translational Medicine associated with 18F-LY3950321
100 Patents (Medical) associated with 18F-LY3950321
100 Deals associated with 18F-LY3950321